SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-036963
Filing Date
2022-02-11
Accepted
2022-02-11 16:03:03
Documents
1
Group Members
JOSHUA BARER

Document Format Files

Seq Description Document Type Size
1 SC 13G d311610dsc13g.htm SC 13G 55347
  Complete submission text file 0001193125-22-036963.txt   56863
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Subject) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92432 | Film No.: 22620635
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877
Business Address C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877 301-825-9810
B&S NexImmune Holdco LLC (Filed by) CIK: 0001844967 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G